In vitro human CD4+ T cell response to the vaccinia protective antigens B5R and A33R
Authors:
- Florence Anne CastelliFCFlorence Anne Castelli
- Alicia ProbstAPAlicia Probst
- Natacha SzelyNSNatacha Szely
- Bernard MaillereBMBernard Maillere
- 1 April 2009
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 46 (7) , 1481-1487
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Antibody Profiling by Proteome Microarray Reveals the Immunogenicity of the Attenuated Smallpox Vaccine Modified Vaccinia Virus Ankara Is Comparable to That of DryvaxJournal of Virology, 2008
- Human CD4+ T Cell Epitopes from Vaccinia Virus Induced by Vaccination or InfectionPLOS Pathogens, 2007
- Human T-Cell Responses to Vaccinia Virus Envelope ProteinsJournal of Virology, 2006
- Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccineVaccine, 2006
- Quantitative and qualitative assessment of circulating NY-ESO-1 specific CD4+ T cells in cancer-free individualsClinical Immunology, 2005
- Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challengeVaccine, 2004
- Protection against Lethal Vaccinia Virus Challenge in HLA-A2 Transgenic Mice by Immunization with a Single CD8+T-Cell Peptide Epitope of Vaccinia and Variola VirusesJournal of Virology, 2004
- Distinct Time Effects of Vaccination on Long-Term Proliferative and IFN-γ–producing T Cell Memory to Smallpox in HumansJournal of Experimental Medicine, 2004
- Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic CellsJournal of Experimental Medicine, 2002
- Preparation of Cell Cultures and Vaccinia Virus StocksCurrent Protocols in Molecular Biology, 1998